• Wrap Technologies, Inc. has appointed former New York City Police Department Deputy Commissioner Edward Delatorre Jr. to its Board of Directors, effective October 20, 2026.
  • Delatorre helped introduce Narcan into NYPD patrol operations, guiding the program from a Staten Island pilot to citywide adoption and later sharing the model with departments nationally and internationally.
  • WRAP(R) sees a direct parallel in its own work: making Non-Lethal Response(TM) technology, training and policy a practical, repeatable capability that agencies can adopt and sustain.

For the NYPD, part of that work was led by Edward Delatorre Jr. Wrap Technologies, Inc. (NASDAQ: WRAP), a provider of non-lethal response technologies and public safety solutions, has appointed Delatorre to its Board of Directors, effective…

Read More

About / Disclaimer

This article was produced by IBN Editorial Staff and is intended for informational purposes only. It is not investment advice and should not be relied upon as the basis for any investment decision. Statements attributed to Wrap Technologies Inc. or its management, including any forward-looking statements regarding product adoption, strategy, the contributions of its Board of Directors, or market opportunities, reflect the company’s views and are subject to risks and uncertainties; actual results may differ materially. Readers should conduct their own due diligence and consult a qualified professional. Additional company information is available at wrap.com.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer

The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP

Forward Looking Statements

Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.